prednimustine has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaufmann, M; Raeth, U; Schmid, H | 1 |
| Bastion, Y; Brice, P; Brousse, N; Haïoun, C; Lepage, E; Moreau, P; Solal-Céligny, P; Straetmans, N; Tabah, I; Tilly, H | 1 |
1 trial(s) available for prednimustine and Disease Exacerbation
| Article | Year |
|---|---|
Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Disease Progression; Drug Administration Schedule; Female; Humans; Interferon-alpha; Lymphoma, Follicular; Male; Middle Aged; Prednimustine; Prospective Studies | 1997 |
1 other study(ies) available for prednimustine and Disease Exacerbation
| Article | Year |
|---|---|
Mitoxantrone and prednimustine combination chemotherapy in breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Progression; Drug Administration Schedule; Female; Humans; Mitoxantrone; Prednimustine; Treatment Outcome | 1989 |